Cromos™ Pharma’s CEO to speak at MAGI Clinical Research Conference in Philadelphia, USA (21-24 May, 2017)
Cromos™ Pharma is pleased to announce that its CEO, Dr. Vlad Bogin, will be speaking at the upcoming MAGI Clinical Research Conference that will take place in Philadelphia, PA, USA on 21-24 May, 2017. Together with his colleagues from Asuragen, Immune Design and Alkerus he will cover the very relevant topic of “How to conduct clinical trials with limited resources.” In addition, Dr. Bogin will chair a panel discussion “Better Communications between Sponsors, CROs and Sites.”
If you plan to attend the conference or to be in Philadelphia on the aforementioned dates, then feel free to set up a face to face meeting with Dr. Bogin directly.
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include clinical monitoring, regulatory approvals, medical writing, feasibility assessments, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.
